Axovant Sciences Ltd. | Key People and Executives
George W. Bickerstaff
Director
Atul C. Pande
Independent Non-Executive Director
Berndt A. E. Modig
Independent Non-Executive Director
Pavan Cheruvu
Chief Executive Officer
Gregory Mark Weinhoff
Chief Financial & Accounting Officer
Ilise D. Lombardo
Chief Medical Officer
Gavin R. Corcoran
Executive Vice President-Research & Development
J. Fraser Wright
Chief Technology Officer
Shankar Ramaswamy
Senior Vice President-Business Development
Thomas S. Templeman
SVP-Pharmaceutical Operations & Quality Assurance
George W. Bickerstaff
Director
Michael Adasczik
Principal Accounting Officer
Tricia Truehart
Head-Investor Relation
Frederick Stephen Mohr
General Counsel
Atul C. Pande
Independent Non-Executive Director
Berndt A. E. Modig
Independent Non-Executive Director
| Address |
11-12 St. James's Square
London London & South East SWIY 4LB
United Kingdom
|
|
Employees
|
- |
| Website |
http://www.axovant.com |
| Updated |
09/14/2018 |
| Axovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel therapeutics in the fields of neurology and psychiatry. Its therapeutic focus are Parkinson's Disease and Lewy Body Dementia. It operates through the following geographical sgements: United States, Switzerland, Bermuda, and Other. |
